Anti-Trichomonas vaginalis activity of chalcone and amino-analogues
Trichomoniasis is the most common non-viral sexually transmitted disease worldwide and can lead to serious consequences in reproductive health, cancer, and HIV acquisition. The current approved treatment present adverse effects and drug resistance data on this neglected parasitic infection is underestimated. Chalcones are a family of molecules that present biological applications, such as activity against many pathogenic organisms including protozoan pathogens. Chalcone (1) and three amino-analogues (2–4) were synthesized by Claisen–Schmidt condensation reaction and had their activity evaluated against the parasitic protozoan Trichomonas vaginalis. This bioassay indicated the presence and position of the amino group on ring A was crucial for anti-T. vaginalis activity. Among these, 3′-aminochalcone (3) presented the most potent effect and showed high cytotoxicity against human vaginal cells. On the other hand, 3 was not able to exhibit toxicity against Galleria mellonella larvae, as well as the hemolytic effect on human erythrocytes. Trophozoites of T. vaginalis were treated with 3, and did not present significant reactive oxygen species (ROS) accumulation, but induced a significantly higher ROS accumulation in human neutrophils after co-incubation. T. vaginalis pyruvate:ferredoxin oxidoreductase (PFOR) and β-tubulin gene expression was not affected by 3.
KeywordsTrichomonas vaginalis Trichomoniasis Chalcone Antiprotozoal Antiparasitic
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil), Marine Biotechnology Program (A.J.M., RedeMarAtivo, grant 408578/2013–0) and Universal Program (D.S.T., grant 443150/2014–1) supported this study. A.J.M., L.O.R, and T.T. thank CNPq for researcher fellowships (grants 303353/2016–3, 306251/2016–7, 312292/2017–1, respectively).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Alderete JF, Garza GE (1985) Specific nature of Trichomonas vaginalis parasitism of host cell surfaces. Infect Immun 50:701–708Google Scholar
- Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77–89Google Scholar
- Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG (1997) Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24(6):353–360CrossRefGoogle Scholar
- Das M, Manna K (2016) Chalcone scaffold in anticancer armamentarium: a molecular insight. J Toxicol 2016:7651047Google Scholar
- Kirkcaldy RD, Augostini P, Asbel LE, Bernstein KT, Kerani RP, Mettenbrink CJ, Pathela P, Schwebke JR, Secor WE, Workowski KA, Davis D, Braxton J, Weinstock HS (2012) Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD surveillance network, 2009-2010. Emerg Infect Dis 18:939–943CrossRefGoogle Scholar
- Singh G, Arora A, Mangat SS, Rani S, Kaur H, Goyal K, Sehgal R, Maurya IK, Tewari R, Choquesillo-Lazarte D, Sahoo S, Kaur N (2016) Design, synthesis and biological evaluation of chalconyl blended triazole allied organosilatranes as giardicidal and trichomonacidal agents. Eur J Med Chem 108:287–300CrossRefGoogle Scholar
- World Health Organisation (2012) Global incidence and prevalence of selected curable sexually transmitted infections – 2008. WHO, GenevaGoogle Scholar